Fecal transplant for gut problems after stem cell transplant
Treatments studied
Part of Digestive system clinical trials.
This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 22 years old
- You had a stem cell transplant from a donor at least 30 days ago
- You have persistent gut problems like diarrhea for 4 weeks or more, or a steroid-resistant or steroid-dependent gut condition
- You are not pregnant or breastfeeding
- You have no history of severe food allergies that could be triggered by the donor's diet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a fecal transplant (transferring healthy bacteria from a donor's stool into your gut) can help people with severe gut graft-versus-host disease that hasn't responded to steroids. It's for patients who have had a stem cell transplant and now have ongoing, severe gut symptoms.
This study tests whether a fecal microbiota transplant (FMT) — putting healthy donor bacteria into your gut — can help your immune system recover better after a stem cell transplant. It is for people whose immune markers are still low 6 months after transplant.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This Phase 1 study tests whether a fecal microbiota transplant (a stool-based treatment from a screened donor) plus a dietary fiber supplement can improve gut symptoms after a bone marrow transplant. It is aimed at people with mild to severe gut graft-versus-host disease (GVHD).
This Phase 2 study tests whether a fecal microbiota transplant (a processed transplant of gut bacteria) after an allogeneic bone marrow transplant is safe and helpful. Participants may benefit by improving recovery in the gut microbiome during the post-transplant period.
This trial tests whether transplanting healthy donor bacteria (fecal microbiota) into the gut can help adults with blood cancers who have stubborn infections, C. diff, or complications after stem cell transplant. It may reduce dangerous germs and improve gut health.
Hear when a new Gastro-Intestinal Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.